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We are developing a genetic map of the dog based partly upon markers contained 
within known genes. In order to facilitate the development of these markers, we 
have used polymerase chain reaction (PCR) primers designed to conserved 
regions of genes that have been sequenced in at least two species. We have refined 
the method for designing primers to maximize the number that produce success- 
ful amplifications across as many mammalian species as possible. We report the 
development of primer sets for 11 loci in detail." C F T R ,  COL10A1,  C S F I R ,  
C Y P I A 1 ,  DCN1,  FES ,  G H R ,  GLB1,  P K L R ,  P V A L B ,  and RB1. We also 
report an additional 75 primer sets in the appendices. The PCR products were 
sequenced to show that the primers amplify the expected canine genes. These 
primer sets thus define a class of gene-specific sequence-tagged sites (STSs). 
There are a number of uses for these STSs, including the rapid development of 
various linkage tools and the rapid testing of genomic and cDNA libraries for the 
presence of their corresponding genes. Six of the eleven gene targets reported in 
detail have been proposed to serve as "anchored reference loci'for the develop- 
ment of mammalian genetic maps [O'Brien, S. J., et al., Nat .  Gene t .  3:103, 
1993]. The primer sets should cover a significant portion of the canine genome 
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for the development of a linkage map. In order to determine how useful these 
primer sets would be for the other genome projects, we tested the 11 primer sets on 
the DNA from species representing five mammalian orders. Eighty-four percent 
of the gene-species combinations amplified successfully. We have named these 
primer sets "universal mammalian sequence-tagged sites" because they should 
be useful for many mammalian genome projects. 
KEY WORDS: genome mapping; evolution; homology; polymerase chain reaction. 
INTRODUCTION 
Efforts have intensified in recent years to develop comprehensive genomic 
maps for many eukaryotic species using molecular techniques. Many of 
these efforts have focused on mammalian species, including human, mouse, 
rat, ox, sheep, pig, horse, cat, and dog (e.g., Buchanan et aL, 1994; Dietrich et 
aL, 1992; Ellegren et al., 1992; O'Brien, 1986; Serikawa et aL, 1992; Weiss- 
bach et aL, 1992; WinterO et al., 1991; Barendse et aL, 1994; present report). 
For the nonhuman species, these projects should lead to more successful 
breeding strategies, both for selecting desirable characteristics and for 
removing genes that lead to various genetic diseases. Comparisons made 
between these genome maps should also lead to new insights on the 
mechanisms of chromosomal evolution (e.g., see O'Brien et aL, 1993). 
We are developing a comprehensive map of the canine genome, with 
our ultimate aim being to reduce the incidence of canine genetic diseases. In 
addition to developing random, highly polymorphic genetic markers (Type 2 
markers), we are also developing markers for specific genes (Type 1 mark- 
ers). An appropriate mix of these two types of markers should maximize our 
ability to map disease genes. 
The traditional method for developing gene-specific markers, Southern 
blotting and cross-species hybridization, is very time-consuming, labor inten- 
sive, and limited in flexibility. This method has been the mainstay for 
developing gene-specific markers in most animal genome projects. There is a 
need to develop more efficient methods. This is particularly important for 
animal genome projects, where scientific resources are more limited. One 
method that has excellent potential is the cross-species polymerase chain 
reaction (PCR). This method has been used successfully for the study of a 
number of individual genes but has not been applied on a genomewide basis 
for the purpose of map development. To study a single gene, the cost 
associated with the failure of a few primers sets to amplify the correct target 
is negligible and new primer sets can be easily redesigned and synthesized. 
However, when primer sets are being designed for many genes, the cost for 
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failed primers can become substantial, in terms of both time and other 
resources, so we have refined the design method to minimize this problem. 
We describe here, in detail, 11 primer sets that can amplify gene- 
specific targets of dogs and other mammalian species. Seventy-five addi- 
tional primer sets are listed in the Appendixes. Because markers based on 
PCR primers are called sequence-tagged sites [STSs (Olsen et al., 1989)], we 
call these primer sets universal mammalian STSs (UM-STSs) because they 
should be useful for many mammalian genome projects. 
MATERIALS AND METHODS 
DNA Isolation 
DNA from dog, human, pigtail macaque, horse, pig, rat, and mouse were 
isolated from various tissues by standard phenol-chloroform extraction 
methods (Sambrook et al., 1989). Goat DNA was kindly supplied by Dr. 
Karen Friderici, Michigan State University. DNA was purified by standard 
methods from a canine liver cDNA library (Clontech) and from a canine 
genomic DNA library (Clontech) after growing 1 x 106 phage in Escherichia 
coli strain LE392 (Murray et al., 1977) in liquid culture (Sambrook et al., 
1989). 
Design of PCR Primers 
Primers were designed to genes where the intron-exon structure was known 
in at least one species and where the nucleotide sequence was known in at 
least two species (the "index species") that are not closely related. Tan- 
demly duplicated genes known to have undergone gene conversion in any 
species were avoided. Primers were generally designed so that the amplified 
product contained an intron. We have followed the human gene nomencla- 
ture system (ISGN, 1987) for naming the canine genes. The 11 loci described 
in detail in this paper, and their protein products, are as follows: CFTR, 
cystic fibrosis transmembrane regulator; COLIOA1, type X collagen, oq 
chain; CSFIR, colony stimulating factor 1 receptor; CYP1A1, cytochrome 
P-450 1, ~1; DCN1, decorin; FES, c-fes (feline sarcoma) protooncogene; 
GHR, growth hormone receptor; GLB1, [3-galactosidase; PKLR, pyruvate 
kinase--liver, RBC form; PVALB, parvalbumin; and RB1, retinoblastoma 
protein. The Genbank Accession numbers or reference for the sequence of 
the two index species for each locus are as follows: CFTR, M55129 and 
M60493; COLIOA1, X65120 and X65121; CSFIR, X14720 and K01643; 
CYP1A1 (Uchida et al., 1990), X04300; DCN1, L01125 and Z12298; FES, 
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X06292 and J02088; GHR, Zl1802 and J04811; GLB1, $59584 and M57734; 
PVALB, X63578 and M15452; PKLR, $59798 and M17088; and RB1, Ll1910 
and M26391. 
Primers were designed to highly conserved nucleotide sequences con- 
tained within coding regions. Additional considerations taken into account 
were degeneracy of underlying codons (Li and Grauer, 1987), overall amino 
acid mutability of the primer region (Collins and Jukes, 1994), placement of 
the 3' end of the primer with respect to amino acid mutability, and good 
standard design practices such as avoidance of primer-dimers. Conservation 
of amino acids within multigene families was also taken into account, when 
possible. Where unavoidable nucleotide mismatches occurred between the 
two index species, the primer sequence was designed to match exactly one of 
the two, which we then call the "primary" index species. GC-rich genes were 
generally avoided due to the amplification difficulties that can occur, even 
with exactly matching primers. Primers were 20 bp in length on average. 
Each primer in a pair was adjusted to be of approximately the same 
annealing temperature (Breslauer et al., 1986). All sets of primer pairs were 
designed to have approximately the same annealing temperature as well, in 
anticipation of performing multiplex amplifications. It was not always pos- 
sible to follow every rule for every gene, given the actual circumstances; 
however, the majority of the rules was generally applicable. Primers were 
synthesized by either the Michigan State University Macromolecular Struc- 
ture Facility or the University of Michigan DNA Synthesis Facility. 
PCR Amplifications 
Correct design and syntheses of the primers were examined by amplifying 
the DNA from the primary index species. Standard buffer, nucleotide, and 
primer concentrations were 50 mM Tris-HC1 (pH 8.3 at room temperature), 
50 mM KC1, 1.5 mM MgCI2, 200 ~ dNTPs, 0.1 ~g of each primer, and 
0.5-1.0 ~g of target DNA in a 25-pA reaction. Reactions were routinely 
boiled for 3 min prior to the addition of 2.0 U of Taq DNA polymerase. 
Optimal cycling conditions for the amplification of canine genomic DNA 
were usually found by testing one of several sets of conditions in general use 
in the laboratory. Occasionally it was necessary to use "hot-start" conditions 
(Bassam and Caetano-Anolles, 1993) in order to get stronger, cleaner 
amplifications. The presence of an amplification product was determined by 
electrophoresis of a portion of the reaction on a 1% agarose TBE gel 
(TBE = 90 mM Tris, pH 8.3, 90 mM sodium borate, 2.5 mM EDTA), 
followed by staining with ethidium bromide. 
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DNA Sequence Analysis 
The identity of each amplified canine gene was confirmed by "single-pass" 
direct sequencing of PCR products using Sequenase or Taq cycle sequencing 
kits (United States Biochemical Corp., Cleveland, OH). The PCR products 
were gel purified with Qiaex (Qiagen Corp., Chatsworth, CA) or by elution 
from polyacrylamide gel slices (Bergenhem et aL, 1992) prior to their use in 
the sequencing reactions. The canine sequences were visually aligned with 
the sequences of the other species used to design the PCR primers in order 
to verify the degree of sequence identity. 
RESULTS 
The primer sets for the various UM-STSs reported here are given in Table I 
and efficient amplification conditions for the canine genes are given in Table 
II. It is probable that these conditions could be optimized further (e.g., 
reduction in the time in each cycle). However, the conditions reported here 
were found to work effectively while minimizing the number of conditions 
that had to be examined. A representative gel showing amplification of the 
canine target DNA along with the human target DNA is shown in Fig. 1. The 
human target serves as a positive control for the amplification system 
because these primers were designed to match the human sequence exactly. 
The ability to quickly screen genomic and cDNA libraries for the presence of 
sequences is also demonstrated in Fig. 1. The genomic clones for GHR, 
COLIOA1, and DCN1 [a very faint signal, stronger on other gels (data not 
shown)] are present in this particular canine genomic library. The presence 
of a decorin cDNA clone (encoded by the DCN1 locus) in the canine liver 
cDNA library is shown by the presence of the 122-bp band; cDNA clones for 
GHR and COLIOA1 are not present. The DCN1 PCR product from the 
cDNA library was sequenced and its identity confirmed (see Fig. 2). The 
human and canine genomic bands have different sizes for GHR and DCN1 
because of the intron size differences. The size for the COLIOA1 PCR 
product is the same between the species because an intron was not spanned, 
for this is the UM-STS. Although the PCR product bands in Fig. 1 are 
unique, a few UM-STS-species combinations sometimes contained one to 
several nonspecific amplification products. This is a minor problem with 
unique sequence primers, because it is almost always possible to deduce the 
correct band based upon staining intensity and on the similarity in size 
compared to the band of the primary index species. 
The amplified products for all of the canine loci were sequenced to 
confirm their identity and the results are shown in Fig. 2. The degree of 
identity between the canine and the index species sequences for each locus is 
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Table II. Amplification Conditions for Canine UM-STSs 
Size of PCR product (bp) 
Locus Temperatures (°C) Times (min) Human Dog 
327 
CFTR 95, 57, 72 0.5, 1.5, 4 700 1000 
COLIOA1 94, 57, 72 (hs) a 1, 2, 3 384 384 
CSF1R 94, 59, 72 1, 2, 3 730 730 
CYPIA1 95, 57, 72 0.5, 1.5, 4 700 600 
DCN1 94, 57, 72 1, 2, 3 1422 2000 
FES 94, 57, 72 0.5, 1, 1.5 484 500 
GHR 94, 57, 72 1, 2, 3 765 800 
GLB1 94, 57, 72 1, 2, 3 238 240 
PKLR 94, 59, 72 1, 2, 3 600 630 
PVALB 94, 57, 72 (hs) 0.5, 1.5, 4 1400 1300 
RB1 94, 59, 72 1, 2, 3 695 1300 
ahs indicates "hot start" used. 
within the range generally accepted (roughly 70 to 100%) as demonstrating 
homology between the genes of mammalian species (Li and Grauer, 1987). 
These results support the hypotheses that the canine PCR products are 
homologous to the respective index species' genes. The canine COLIOA1 
sequence matched the human and mouse sequences to a similar extent (data 
not shown). The sequences for PKLR and CYP1A1 exactly matched previ- 
ously published canine coding sequences (Whitney et al., 1994; Uchida et al., 
1990); the sequence for canine FES is given in Fig. 3. Although the majority 
of the canine sequence for PVALB is from an intron, we believe that the 
degree of sequence identity from this region is sufficient evidence to confirm 
that the PCR product is from the correct canine locus. As expected, the 
canine sequences tend to show greater identity with the human sequences 
than with the rodent sequences because of the faster evolutionary rate of the 
rodent genome (Gu and Li, 1993). A microsatellite repeat was found within 
the amplified product itself for RB1. Preliminary results show that the RB1 
repeat, (GA)l;(avg), has moderate genetic variability within several canine 
breeds. 
We hypothesized that each primer set should work for many mammals, 
given the evolutionary rate at which nucleotide substitutions occur (Li and 
Grauer, 1987) and the number of primer nucleotide mismatches that can be 
tolerated by PCR. We tested the "universal" utility of these primers on the 
DNAs from mammals representing several different orders. We used the 
same reaction conditions that were found to amplify the canine sequences. 
We have termed these reactions "Zoo PCRs." Figure 4 shows a representa- 
tive experiment. The FES protooncogene was amplified from all of the 
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Fig. 1. Amplification of several canine gene segments using UM-STSs. The 
following lanes were amplified with the gene-specific primer sets (see Table I): 
lanes 1-4, GHR; lanes 5-8, COLIOA1; and lanes 9-12, DCN1. Lane 13 
contains a mixture of DNA size markers; X bacteriophage DNA cut with the 
restriction endonuclease BstEII and the plasmid pSK- (Stratagene) cut with 
MspI. Lanes 1, 5, and 9 contain PCR products amplified from human genomic 
DNA. Lanes 2, 6, and 10 contain PCR products amplified from canine 
genomic DNA. Lanes 3, 7, and 11 contain PCR products amplified from DNA 
purified from a canine genomic library contained in a ~. bacteriophage vector. 
Lanes 4, 8, and 12 contain PCR products amplified from a canine liver cDNA 
library. 
DNAs examined. These PCR products were purified and sequenced directly 
without subcloning (see Methods and Materials). The sequences are tabu- 
lated in Fig. 3. The degree of sequence identity makes it highly likely that the 
canine PCR products are all homologous to the corresponding index spe- 
cies' genes. The pattern of nucleotide interchange is also what would be 
expected for homologous genes; members of the same mammalian order 
share more sequence similarity with one another than with those of other 
orders. 
The data for the Zoo PCRs for the other UM-STS primer sets reported 
in this paper are given in Table III. More than 84% of the targets, excluding 
the index and canine species, amplified under the single condition used to 
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amplify the canine sequence. These species represent five mammalian 
orders: primates (human and macaque), carnivores (dog), artiodactyls (goat 
and pig), perissodactyls (horse), and rodents (mouse and rat). Limited 
experiments on other members of these orders (e.g., cat and ox) produced 
similar results (data not shown). Lack of amplification for DCN1 for one of 
the artiodactyls (goat) would be predicted because there are four mis- 
matches between the UM-STS primers and the sequence of the closely 
related bov ineDCN1  (Day et al., 1987). We have found it difficult (although 
not impossible) to amplify DNA using primers that contain more than two 
mismatches with the target when using 20-mers (P.V., unpublished results). 
It is likely that the homologous gene from at least some of the nonamplifying 
species would appear using these primer sets if other PCR conditions were 
examined. 
DISCUSSION 
This study has shown the feasibility of generating a series of UM-STSs, 
useful for studies of many genomes, and addressed methodological consider- 
ations for their development. UM-STSs should serve as useful tools both for 
amplifying regions of interest from genomes and for isolation of clones from 
genomic and cDNA libraries and cross-species comparisons. The data 
reported in this paper indicate that approximately 85% of all carefully 
designed UM-STSs will be useful for any given mammalian species. We 
believe that this method is far more efficient, less costly, and considerably 
less labor intensive than traditional hybridization and Southern blotting- 
based methods. An additional important benefit is that the information for 
the necessary reagents (i.e., the primer sequences) is transmitted much 
more easily and quickly than the clones that are necessary for Southern 
blotting. 
UM-STSs will also be useful for developing genetic markers within 
various genomes. We have found a microsatellite within 1 of the 11 loci 
reported here (RB1) and have found other microsatellite repeats associated 
with genomic clones isolated through the use of UM-STSs (unpublished 
results). Single-site variability should also be found directly in at least some 
of the amplified products by using one of a number of techniques developed 
for scanning for variability, such as the single-strand conformation polymor- 
phism technique. For example, this method has been used to find two 
polymorphic sites in a study of the canineALAS2 gene in a PCR product of a 
size similar to those reported here (Boyer et al., 1995). If the frequency of 
single site polymorphic variability for other mammals is as high as that 
estimated for humans (roughly 1 in 200-400 nucleotides), then a significant 
portion of UM-STSs will have these sites. We are currently screening for this 
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CFTR 
A.A. 1346 
1 intron 22 
Dog . . . . . . .  ] I . . . .  
Mo~ise . . . . . . . .  I I V - - V . . . . . .  
Human E P S A H L D P I V T Y Q I I R R T L K Q A F A 
Human GAACCCAGTGCTCATTTGGATCC 1AGTAACATACCAAATAATTAGAAGAACTCTAAAACAAGCATTTGCT 
Mouse . .G ........ C...C.A..C.. ]CA ........... G.C...C..C..GT ............ C..C... 




Dog . . . . . . . .  K . . . . . . . . . . . . .  H 
Mouse I Y E . . . . . . . . . . . .  S . . . . .  K 
Human P F D K I L Y N R Q Q H Y D P R T G I F T C Q 
Human CCATTTGATAAAATTTTGTATAACAGGCAACAGCATTATGACCCAAGGACTGGAATCTTTACTTGTCAG 
Mouse . .CA..T, .G.G...C .... C..T ..... G ........ C ........ AT .... T ........ C...A.. 
Dog ........... G..C .......... A ..................... A ........... C..C..C..C 
CSFIR 
A.A. 107 
intron 3 1 
Dog [ - V - Q . . . . . . . .  v G . . . . .  
FeLV I - A Q . . . . . .  T L G . . . . .  
Human I D P A R P W N V L A Q E V V V F E D Q D A L L 
Human ] ACCCTGCCCGGCCCTGGAACGTGCTAGCACAGGAGGTGGTCGTGTTCGAGGACCAGGACGCACTACTGC 
FeLV ] ....... T ..... T ..... G ..... G, .C ..... A.. ,ACG ..... G..A.GT ..... T..GT.G .... 
Dog I ...... TT ..... T ..... G ..... G..G ........ C ...... G ...... GG ..... T..G, .G .... 
DCNI 
A.A. 231 
] intron 6 
Dog . . . . . .  ] . . . . . . . . . .  
Rat . . . . . . . .  N S - S I . . . . . . . . . .  
H u m a n V D A A S L K G L N N L A I K L G L S F N S I S  
Htunan GTTGATGCAGCTAGCCTGAAAGGACTGAATAATTTGGCTAIAGTTGGGATTGAGTTTCAACAGCATCTCT 
Rat ........... C ............ A..TC ....... T...]..C .... T ..... C ..... T ...... A.C 




Dog - D L . . . . .  G . . . . . . . .  N . . . . .  
Rat D A . . . . . . . . . . . . . .  D Q - 
Human D E P D E K T E E S D T D R L L S S D H E K S 
Htuman TGATGAGCCAGATGAAAAGACTGAGGAATCAGACACAGACAGACTTCTAAGCAGTGAC CATGAGAAATCA 
Rat ...... TG.G ..... G ........ A..G ........ C ............... GA ...... G ......... 
Dog ...... C.T ............ C..A.G .......................... AC ............... 
Fig. 2. Lineups of several canine gene sequences with homologous mammalian genes. 
The nucleotide and amino acid sequences are compared for each of several anchor loci 
between dog and two other species. The locations of PCR primers are underlined, 
although not all PCR primer sites are shown. Some of the lineups show intron sequence, 
whereas others simply identify the location of the introns. Genbank accession numbers 
for the canine sequences are as follows: CFTR, L77683 and L77689; COLIOA1, L77672; 
CSF1R, L77670; DCN1, L77684; GHR, L77673; GLB1, L77671; PVALB, L77685 and 
L77686; and RB1, L77669. 




Dog . . . . . . . . .  V - - V 
Mouse . . . . . . . . . . .  K . . . .  V - K T L T 
Human E F Y T G W L D H W G Q P H S T I K T E A V A S 
Human GAATTCTATACTGGCTGGCTAGATCACTGGGGCCAACCTCACTCCACAATCAAGACCGAAGCAGTGGCTTCC 
Mouse . .G .................... C ........ TA .... C..T ..... GG.G..A..TA..A..C ..... A.. 




Dog i n t r o n  2 
Rat . . . . . . .  (bp) S 
Human I E E D E L G F I L K 
Human ATCGAGGAGGATGAGCTGGGg t a agc t ggagg 1300 t t t c t cct c cagATTCATCCTAAAAG 
Rat . .T ..................... a. 1500 - . ...... - .... G.C...T..G..G. 
Dog ....... agactcc. 1300 ....... - ............ 
RBI 
A.A. 890 
[ intron 22 
Dog A . . . . . . . . . .  L . . . . . . . . . . . .  I 
Mouse G . . . . . . .  N V . . . . . .  A . . . . . .  I 
Human G S N P P K P L K K L R F D I E G S D E A D G S I 
Human GGAAGCAACCCTCCTAAACCACTGAAAAAACTACGCTTTGATATTGAAGGATCAGATGAAGCAGATGGAAG I 
Mouse . .CG ....... C..C .............. CG.G ........ C..C..G...G.C .............. G.. I 
Dog .C ................... T ............ TG ........ C .......................... I 
Fig. 2. (continued) 
variability in the canine genome to estimate the frequency of such variation 
in the dog. It will be necessary to screen each species individually for genetic 
variability. However, the availability of previously designed UM-STS primer 
sets, such as those reported here, should make this work proceed more 
rapidly compared to the traditional method. 
An example of the utility of cross-species comparisons is given by the 
case of Waardenburg syndrome. The clue to the location of one of the 
human Waardenburg syndrome genes--well-known for causing a syndromic 
hearing loss--was first gleaned from comparative mapping with the mouse 
(Asher and Friedman, 1990). The map locations in the mouse suggested 
possible locations of the human disease gene, one of which eventually was 
proven correct (e.g., Morell et  al., 1992). Because the identity of the gene in 
the mouse was not known at the time, this approach might more properly be 
called a "positional candidate" approach. UM-STSs will be useful for 
rapidly producing mammalian genetic maps so that the positional candidate 
approach can be applied to more species. 
Very little is known about the location of genes within the canine 
genome. Indeed, except for genes located on the X chromosome (Meera- 
Khan, 1984; Deschenes et  al., 1994) and a few small unassigned linkage 
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A D N T L V A V K S C R E T L P P D L K 
GCCGACAACACCCTGGTGGCGGTGAAGTCTTGTAGAGAGACGCTCCCACCTGACCTCAAG 
............ T ....... n ................................. n ..... 
............ T ....... C ..... A ...... C.C ..... A ............ A ..... 
........... T ........ C ..... A ...... C.C ..... A ..... A ...... A ..... 
........ T..T .............. A ..... CC ....... C .................. 
. .A ....................... A ...... C.C ..... A .................. 
• .A ....................... A ...... C ....... A..G..C ............ 
• .A..T .................... A ..... CC .... A ..................... 
• .T ........ ............... A ..... CC ............. C..G ......... 
• .A .......... C ...... T ............ C ................... N ...... 
................. W ............ C ...... I ~  ................. 
HUM A K F L Q E A R  
HUM GCCAAGTTTCTACAGGAAGCGAG GTGGGTGATAAACTAATGATCACCACGGGTCCCGCAT 
MAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
DOG .............................. C .... G...C...--..CA.A.CT..A... 
CAT ........... T ........ A.A ..A .... AC...AG..C...--..CATAA.T ..... C 
FES ........... T ........ A.A 
COW ........... C ..................... G.AC.CCC...A.TGTA..C...CATA 
GOA ........... G ........ A ............ G.AC.CC...A.TGTA..C...T.C.C 
PIG ........... G ....................... AG..CC .... TGTGATAAAAGA.CC 
HOR ................. G..A .......... C...A...CC .... TGGTAT.CTAA.G.. 
RAT ........... G..NNNN ........... C ..... A.GGGA.CAGT..A..T...TTGTG 
MOU .................... A .............. A .... AT 
Fig. 3. Sequence of a portion of the FES protooncogene from several mammalian DNAs. 
Sequences are from exon 15 and intron 15. Notations for the sequence lineups are as 
follows: HUM, human; MAC, macaque; CAT, domestic cat; FES, feline sarcoma virus; 
DOG, dog; COW, ox; GOA, goat; HOR, horse; PIG, pig; RAT, rat; and MOU, mouse. The 
upper two lines for each block of text represent amino acid sequences and the lower lines 
represent nucleotide sequences. Dots indicate nucleotides in the various species that are 
identical to those of the human sequence. The human and cat sequences determined here 
exactly match the published sequences (Alcalay et al., 1990; Roebroek et al., 1987). The 
feline sarcoma virus sequence was not determined in this study but is included for 
comparative purposes. Only a single amino acid interchange was found among these 
sequences; isoleucine (I) for macaque, cat, and feline sarcoma virus and leucine (L) in all 
others. Sequence alignments for the intron were done visually and may not be optimal. 
Genbank accession numbers for these sequences are as follows: MACFES, L77678; 
DOGFES, L77674; CATFES, L77675; COWFES, L77677; GOAFES, L77681; PIGFES, 
L77679; HORFES, L77676; RA TFES, L77680; and MOUFES, L77682. 
groups (Meera-Khan, 1984), their locations (Holmes et aL, 1992; Ostrander 
et aL, 1993; Rothuizen et al., 1994; Yuzbasiyan-Gurkan et aL, 1993) are based 
primarily on simple sequence repeats. The development of UM-STSs should 
help to identify rapidly the location of linkage groups on specific canine 
chromosomes. The identification of conserved syntenies will allow candidate 
linkages to be tested in the canine genome. The assignment of the proposed 
anchor loci (O'Brien et al., 1993) as defined by UM-STSs to specific 
chromosomes can be accomplished by the somatic cell hybrid, flow sorted 
chromosome, and fluorescent in situ hybridization (FISH) methodologies. 
Other methods, such as assignment by use of linkage to previously mapped 
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Table III. Summary of Amplification Results for UM-STSs for Several Mammalian DNAs a 
Locus Human Macaque Dog Goat Pig Horse Mouse Rat 
C F T R  + b + + _ + + + + 
C O L I O A 1  + + + - + + + + 
C S F 1 R  + + + + - - + + 
C Y P 1 A 1  + + + + + + + + 
D C N 1  + + + - + + + + 
F E S  + + + + + + + + 
G H R  + + + + + + + + 
G L B 1  + + + + + + + + 
P K L R  + + + + + - + + 
P V A L B  + + + + + + - - 
R B 1  + + + - + + + + 
a +, Amplification; - ,  no amplification. 
bBoldface symbols indicate index species. 
loci, are also possible. We have already assigned several genes by FISH to 
canine chromosomes using cosmids isolated with UM-STSs (Fujita et al., 
1996). Using the methods described here, we have developed a much greater 
number of UM-STSs that should cover, for linkage mapping purposes, a 
substantial portion of the canine and other mammalian genomes (see 
Appendixes i and 2). 
APPENDIX 1 
Table AI. Eighty-Six a Universal Mammalian Sequence-Tagged Sites--Human Chromosomal 
Locations and Names 
Locus Human Primer i Primer 2 
name Gene product chromosome name name 
P N D  Pronatriodilatin 1 p36 
P K L R  Pyruvate kinase--RBC 1 q21 
A T 3  Antithrombin III i q23-q25 
REN Renin 1 q32 
S F T P 3  Pulmonary suffactant 
protein 3 2 p11.2 
S P T B N 1  [3-Spectrin (non-RBC) 2 p21 
A P O B  Apolipoprotein B 2 p24-p23 
I L 1 A  Interleukin lc~ 2 q13 
C O L 3 A 1  Collagen III al  2 q31-q32.3 
E L N  Elastin 2 q31-qter 
P A X 3  Human paired domain 2 2 q34-q36 
G C G  Glucagon 2 q36-q37 
P I T 1  Pituitary-specific tran- 
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Table AI. (continued) 
Locus Human 
name Gene product chromosome 
Primer 1 Primer 2 
name name 
335 
GLB1 ~-galactosidase 3 pter-p21 
GPX1 Glutathione peroxidase 1 3 q11-q12 
TF Transferrin 3 q21 
RHO1 Rhodopsin 3 q21-qter 
GLUT2 Glucose transport-like 2 3 q26.1-q26.3 
SST Somatostatin 3 q28 
HOX7 Homeobox 7 4 p16.1 
PDEB eGMP phosphodiesterase 13 4 pter 
ALB Albumin 4 ql l -q13 
K/T c-KIT protooncogene 4 q12-q13 
FGG Fibrinogen ~ 4 q28 
GHR Growth hormone 
receptor 5 p13.1-p12 
HEXB [3-Hexosaminidase 5 q13 
IL4 Interleukin 4 5 @3-@1 
ADRB2 Adrenergic receptor [~2 5 q31--q32 
CSF1R CSF-1 receptor 5 q33-q35 
TNFA Tumor necrosis factor c~ 6 p21.3 
EDN1 Endothelin 1 6 p24-p23 
COL9A1 Collagen IX ed 6 q12-q14 
COLIOA1 Collagen Type X cd 6 q21-q22 
PLG Plasminogen 6 q25-q27 
EPO Erythropoeitin 7 q21 
CFTR Cystic fibrosis trans, regu- 
lator 7 q31-@2 
TCRB T-cell receptor [3 7 q35 
SFTP2 Pulmonary suractant pro- 
tein 2 8 p21 
CA2 Carbonic anhydrase II 8 q22 
TG Thyroglobulin 8 q24 
ALDOB Aldolase B 9 q21.3-q22.2 
C5 Complement factor 5 9 q22-q34 
ABL ABL protooncogene 9 q34 
RET RET protooncogene 10 q11.2 
TDT Terminal transferase 10 q23-q24 
OAT Ornithine aminotrans- 
ferase 10 q26 
WT1 Wilms tumor 1 11 p13 
LDHA Lactate dehydrogenase A 11 p14-15.5 
INS Insulin 11 p15.5 
CD20 CD20 11 q12-q13.1 
ROM1 Rod outer segment pro- 
tein-1 11 q13 
APOC3 Apolipoprotein C3 11 q23-qter 
VWF von Willebrand's factor 12 p 
LDHB Lactate dehydrogenase B 12p12.1-12.2 
IL6 Interleukin 6 12 p12.2-p12 
TPI Triosphosphate isom- 














































name Gene product 
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Table AI. (continued) 
Human Primer 1 Primer 2 
chromosome name name 
COL2A1 Collagen II a l  
DCN1 Decorin 
IGF1 Insulin-like growth factor 1 
PLA2 Phospholipase A2 
RB1 Retinoblastoma 1 
F7 Clotting factor VII 
CHY Chymase (mast cell) 
CKBB Creatine kinase brain 
TCRA T-cell receptor a 
B2M 1~-2-Microglobulin 
CYP1A1 Cytochrome P-450 
(AHH) 
PKM Pyruvate kinase--muscle 
FES FES protooncogene 
HGBA a-Hemoglobin 
GOT2 Glutamate oxaloacetate 
transaminase 2 
CTRB Chymotrypsinogen 
APRT Adenosine PR trans- 
ferase 
TP53 Tumor protein 53 
NF1 Neurofibromatosis 1 
SCN4A Skeletal muscle sodium 
channel 
TS Thymidylate synthetase 
APOC2 Apolipoprotein C2 
CKMM Creatine kinase muscle 
PVALB Parvalbumin 
D YS Dystrophin 
MNK Menkes protein 
HPRT Hypoxanthine PR trans- 
ferase 
F9 Clotting factor IX 
F8 Clotting factor VIII 
SRY Sex determining 
region--Y 
12 q14.3 HCOL2A1EX2D HCOL2A1EX3U 
12 q21~123 HDCNEX6D HDCNEX7U 
12 q22 HIGF1EX3D HIGF1EX4U 
12 q23-qter DPLA2EX2D DPLA2EX3U 
13 q14.2 HRB1EX25D HRB1EX26U 
13 q34 HF7EX7D HF7EX8U 
14 q11.2 DCHYEX4D DCHYEX5U 
14 q32.3 DCKBEX6D DCKBEX8U 
14 q34 DTCRAEX3D DTCRAEX4U 
15 q21-q22.2 HB2MEX2D HB2MEX3U 
15 q22-q24 DCYP1AIEX3D DCYP1AIEX5U 
15 q22~tter HPKMEX2D HPKMEX3U 
15 q25--qter HFESEX14D HFESEX15U 
16 p13.3 HHGBAEX2D HHGBAEX3U 
16 q21-q22 HGOT2EX5D HGOT2EX7U 
16 q22.3-q23.2 DCTRBEX5D DCTRBEX6U 
16 q24 HAPRTEX3D HAPRTEX5U 
17 p13.1 HTP53EX5D HTP53EX7U 
17 ql l .2 HNF1EX6D HNF1EX7U 
17 q23.1-q25.3 HSCN4AEX23D HSCN4AEX24U 
18 pter-ql2 HTSEX5D HTSEX6U 
19 q13.2 DAPOC2EX3D DAPOC2EX4U 
19 q13.2-q13.3 DCKMEX2D DCKMEX3U 
22 q12-q13.1 HPVALBEX3D HPVALBEX4U 
X p21 DDYSEX7D DDYSEX7U 
X q12~q13.3 HMNKEX4 HMNKEX4 
X q26 HHPRTEX7D HHPRTEX8U 
X q26.3-q27.1 DF9EX7D DF9EX8U 
X q28 HF8EX24D HF8EX25U 
Y pll.3 HSRYEX1D HSRYEX1U 
aFor convenience, the 11 loci described in detail are included in the Appendixes. 
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